Published in Neurosci Res on February 25, 2010
Comparing the predictive value of multiple cognitive, affective, and motor tasks after rodent traumatic brain injury. J Neurotrauma (2012) 1.04
Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imaging (2010) 0.98
Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res (2012) 0.98
Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci (2014) 0.94
Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury. Stem Cells Dev (2015) 0.85
Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences. J Neurosci Methods (2011) 0.82
Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury. PPAR Res (2014) 0.80
New reliable scoring system, Toyama mouse score, to evaluate locomotor function following spinal cord injury in mice. BMC Res Notes (2014) 0.79
The multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2/4/7 expressions in neurons and glial cells. PLoS One (2013) 0.79
Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling. J Cereb Blood Flow Metab (2016) 0.79
Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury. Cell Cycle (2015) 0.77
Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury. Brain Res (2014) 0.76
Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement. J Neuroinflammation (2017) 0.75
Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice. Behav Brain Res (2017) 0.75
Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats. Drug Des Devel Ther (2015) 0.75
The SDF-1/CXCR4 axis promotes recovery after spinal cord injury by mediating bone marrow-derived from mesenchymal stem cells. Oncotarget (2017) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48
Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol (1996) 5.46
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg (1977) 2.09
The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol (1995) 1.78
Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp Neurol (2002) 1.77
Efficient testing of motor function in spinal cord injured rats. Brain Res (2000) 1.61
Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma (2005) 1.60
Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain (2007) 1.56
Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci (1998) 1.53
Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol (1985) 1.50
Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci (2001) 1.46
A mouse model of graded contusive spinal cord injury. J Neurotrauma (1998) 1.42
Spontaneous locomotor recovery in spinal cord injured rats is accompanied by anatomical plasticity of reticulospinal fibers. Eur J Neurosci (2006) 1.39
Advances in secondary spinal cord injury: role of apoptosis. Spine (Phila Pa 1976) (2000) 1.26
Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma (2007) 1.24
Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp Neurol (1999) 1.23
The Louisville Swim Scale: a novel assessment of hindlimb function following spinal cord injury in adult rats. J Neurotrauma (2006) 1.10
Methods for behavioral testing of spinal cord injured rats. Neurosci Biobehav Rev (2007) 1.09
Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci (2006) 1.06
Quantification of locomotor recovery following spinal cord contusion in adult rats. J Neurotrauma (2006) 1.04
Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol (1995) 1.04
Optimization of a mouse locomotor rating system to evaluate compression-induced spinal cord injury: correlation of locomotor and morphological injury indices. J Neurosurg Spine (2006) 0.99
Profound differences in spontaneous long-term functional recovery after defined spinal tract lesions in the rat. J Neurotrauma (2006) 0.96
Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett (1992) 0.96
Biomechanical analysis of experimental spinal cord injury and functional loss. Spine (Phila Pa 1976) (1988) 0.94
Synaptic plasticity modulates the spontaneous recovery of locomotion after spinal cord hemisection. Neurosci Res (2006) 0.94
Adaptation of a ladder beam walking task to assess locomotor recovery in mice following spinal cord injury. Behav Brain Res (2007) 0.91
Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury. Exp Neurol (2006) 0.87
Adaptations in the walking pattern of spinal cord injured rats. J Neurotrauma (2006) 0.86
Locomotor deficits and adaptive mechanisms after thoracic spinal cord contusion in the adult rat. J Neurotrauma (2006) 0.84
Role of microglia in neurotrauma. Neurotherapeutics (2010) 2.53
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci (2010) 2.40
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A (2005) 2.10
Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol (2003) 2.06
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med (2009) 1.95
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev (2006) 1.86
Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain (2007) 1.56
Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics (2010) 1.54
The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J (2006) 1.54
Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase. Anesthesiology (2013) 1.49
Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging (2012) 1.41
Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab (2008) 1.41
Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle (2005) 1.32
Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation (2012) 1.31
Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol (2014) 1.29
Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia (2009) 1.28
BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem (2004) 1.25
Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma (2003) 1.25
The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol Dis (2004) 1.21
Role of cell cycle proteins in CNS injury. Neurochem Res (2007) 1.21
Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci (2003) 1.20
In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem (2004) 1.20
IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum (2013) 1.19
Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol Genomics (2005) 1.19
Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab (2011) 1.19
Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab (2004) 1.16
Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem (2009) 1.15
Expression of two temporally distinct microglia-related gene clusters after spinal cord injury. Glia (2006) 1.14
Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci (2005) 1.14
Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J (2004) 1.09
Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma (2002) 1.07
Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis. J Neurochem (2012) 1.07
Cell cycle activation and CNS injury. Neurotox Res (2009) 1.06
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br J Pharmacol (2005) 1.05
Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol (2009) 1.04
Comparing the predictive value of multiple cognitive, affective, and motor tasks after rodent traumatic brain injury. J Neurotrauma (2012) 1.04
MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J Neurochem (2004) 1.04
Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion. J Neuroinflammation (2012) 1.02
CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury. Neurotherapeutics (2012) 1.02
Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation (2011) 1.01
Fluid-percussion-induced traumatic brain injury model in rats. Nat Protoc (2010) 1.00
Primary microglia isolation from mixed glial cell cultures of neonatal rat brain tissue. J Vis Exp (2012) 0.98
Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res (2012) 0.98
Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imaging (2010) 0.98
Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma (2011) 0.98
Cell cycle activation and spinal cord injury. Neurotherapeutics (2011) 0.97
Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol Biochem Behav (2002) 0.97
Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy (2014) 0.96
Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury. J Neurotrauma (2012) 0.96
Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx (2004) 0.96
Multifunctional drug treatment in neurotrauma. Neurotherapeutics (2009) 0.96
Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury. Neurobiol Dis (2013) 0.96
Quantitation of calcitonin gene-related peptide mRNA and neuronal cell death in facial motor nuclei following axotomy and 633 nm low power laser treatment. Lasers Surg Med (2002) 0.95
Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J Neurotrauma (2013) 0.95
Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo. PLoS One (2012) 0.95
Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J Neurosci Res (2002) 0.93
Mild traumatic brain injury results in depressed cerebral glucose uptake: An (18)FDG PET study. J Neurotrauma (2013) 0.91
TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J Neurosci (2013) 0.91
Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury. Cell Cycle (2012) 0.90
Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury. J Neurotrauma (2006) 0.89
Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment. Involvement of cell cycle activation. Cell Cycle (2014) 0.88
Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem Biophys Res Commun (2002) 0.88
Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Dev Neurosci (2010) 0.88
Novel neuroinflammatory targets in the chronically injured spinal cord. Neurotherapeutics (2011) 0.87
Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury. Neurotherapeutics (2014) 0.87
Dual-confocal fiber-optic method for absolute measurement of refractive index and thickness of optically transparent media. Opt Lett (2002) 0.87
Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion. Neurotherapeutics (2013) 0.86
Microglial activation and traumatic brain injury. Ann Neurol (2011) 0.86
Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiol Dis (2012) 0.86
PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury. J Neurotrauma (2014) 0.85
Metabotropic glutamate receptor-mediated signaling in neuroglia. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.84
The "dark side" of endocannabinoids: a neurotoxic role for anandamide. J Cereb Blood Flow Metab (2004) 0.84
Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. Drug News Perspect (2003) 0.83
Synthesis and biological activity of novel neuroprotective diketopiperazines. Bioorg Med Chem (2002) 0.82
Cell cycle inhibition limits development and maintenance of neuropathic pain following spinal cord injury. Pain (2016) 0.82
Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury. J Cereb Blood Flow Metab (2013) 0.82
Modulation of stretch-induced enhancement of neuronal NMDA receptor current by mGluR1 depends upon presence of glia. J Neurotrauma (2003) 0.81
Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J Neurotrauma (2008) 0.80
Chronic decrease in wakefulness and disruption of sleep-wake behavior after experimental traumatic brain injury. J Neurotrauma (2014) 0.79
808 nm wavelength light induces a dose-dependent alteration in microglial polarization and resultant microglial induced neurite growth. Lasers Surg Med (2013) 0.78
Estimation of ligand efficacies of metabotropic glutamate receptors from conformational forces obtained from molecular dynamics simulations. J Chem Inf Model (2013) 0.78
Changing the name of the journal. NeuroRx (2006) 0.75
Transitions and transformations. Neurotherapeutics (2011) 0.75